To date, in the investigation of the role of S. aureus in WG,we face a paradoxical situation. On the one hand, clinical results obtained from treatment of WGpatients with co-trimoxazole and studies assessing the impact of S. aureus on disease relapses strongly suggest that this bacterium contributes to disease pathophysiology. On the other hand, laboratory investigation of the possible mechanisms by which 5. aureus is involved in WGis scarce, despite the fact that knowledge and tools to study this microorganismare abundant. In the present review, we discuss recent works investigating the possible pathophysiologic contribution of S. aureus to WG.Moreover, we propose a number of possibly relevant pathways of interaction of this bacterium with lymphoid and nonlymphoid cells of the WGhost. (Internal Medicine 42: 771-780, 2003) 
Introduction
Within the group of small vessel vasculitides-a cluster of conditions characterized by inflammation of vessel walls that can lead to systemic organ damage-Wegener's granulomatosis (WG)occupies a distinctive place since it has been particularly well studied from a clinical but also a mechanistic point of view. Frequently commencingwith general, nonspecific symptomsin combination with a chronic respiratory tract infection, WGproceeds in manycases as an autoimmune disorder, hallmarked by the presence of autoantibodies specific for granulocytic enzymes, such as proteinase 3 and myeloperoxidase (1) (2) (3) (4) . If untreated, the disease eventually affects the vasculature of various organs, amongwhich the kidney is the most prominent target. The immunesystem has been the major target of medical intervention in WGand treatment with immunosuppressive drugs such as prednisolone, cyclophosphamide, azathioprine, and, more recently, methotrexate and mofetil mycophenolate is meanwhile established (5). Moreover, our group has proposed treatment with the antibiotic trimethoprimsulfamethoxazole (co-trimoxazole) as a means of reducing the incidence of disease relapses in WG(6). Together with our findings that the incidence of chronic nasal carriage of the gram-positive bacterium Staphylococcus aureus was significantly higher in WGpatients than in healthy individuals, and that chronic carriage of S. aureus constitutes a risk factor for disease exacerbation in WG(7), our study postulated a significant role for S. aureus in disease (re)activation in WG.
In the present review, we will discuss recent work investigating the possible pathophysiologic contribution of S. aureus to WG.Since studies on the involvement of S. aureus in WG are yet scarce, we also propose a number of possibly relevant pathways of interaction of this bacterium with lymphoid and non-lymphoid cells of the WGhost.
S. aureus: Epidemiology
Staphylococcus aureus is a gram-positive bacterium that is most consistently isolated from the anterior nares (8, 9). In various settings and conditions, carriage of S. aureus is elevated; a prominent group at risk for increased S. aureus carriage is patients whoregularly use needles, such as dialysis patients, diabetes patients, but also patients with skin lesions, AIDS or undergoing surgery (reviewed in 10). In these patients carriage can be associated with the development of clinical S. aureus infections.
S. aureus in WG: Clinical Evidence
Friedrich Wegenerwas the first to postulate that a micro- In order to determine whether S. aureus is implicated in disease exacerbation in WG,we conducted a prospective study, assessing nasal carriage of S. aureus and its impact on disease reactivation (7). Chronic nasal carriage of S. aureus was defined as the presence of >75%of nasal cultures positive for this bacterium (cultures were obtained every 4-6 weeks). By this criterion, 36/57 patients (63%) were chronic nasal carriers of S. aureus, a rate approximately three times higher than in healthy controls. Relapses occurred predominantly in chronic carriers of S. aureus (relative risk of carriage for ensuing relapse, 7.16).
In the following sections we will review mechanismsby which this bacterium may be implicated in the pathogenesis of this form of vasculitis.
Impact of S. aureus on T Cells in WG
The main influence of S. aureus on T cells is exerted by its exotoxins. Three classes of exotoxins have been described to date, comprising the staphylococcal enterotoxins (SE), exfoliative toxins (ET) and toxic-shock syndrome toxin 1 (TSST-1).
Although initially described as toxic agents responsible for the development of food poisoning (SE) (25), skin exfoliation (ET) and toxic shock (TSST-1) (26), staphylococcal exotoxins were soon recognized as extremely potent immunostimulatory molecules, and therefore termed "super- vivo. In the second phase, the T-cell response to SAgis contained and terminated. This phase is dependent on chronicor restimulation with the original SAg and is modulated by the production of the immunosuppressive cytokine IL-10 (37-39). An anergic state sets in, marked by the inability of previously stimulated T cells to produce IL-2 and to prolifer- and SAgproducing S. aureus strains has been assessed (51-53), demonstrating the correlation between the presence of TSST-1 producing S. aureus, the presence of corresponding Vp2+ T cell expansions and concomitant vasculitic disease activity. In WG,the increased incidence of chronic nasal carriage of S. aureus (24), together with the finding that circulating T cells are chronically activated (54, 55) support the hypothesis that a persistent stimulus, possibly a staphylococcal SAg, may contribute to T cell activation and thus to disease reactivation (54) . present SAgin these strains, although their presence was not significantly more frequent than in S. aureus strains obtained from healthy individuals. However, in this preliminary study, SAg-positive S. aureus did identify a subgroup of WGpatients with a higher risk for the development of disease relapses (57) . Very recently we have extended our study to comprise 709 S. aureus strains isolated from 63 WGpatients over a time period of 6 years. Typing of SAg genes in these strains by PCR confirmed our previous finding of SEA, TSST-1, SEC and ETAbeing the most frequently occurring SAg ( Table 1) .
Analysis of the time-dependent relation between the occurrence of relapses and SAg-carriage identified TSST-1 as a risk factor for disease exacerbation (E.R.P, manuscript in and particularly marked skewing of Vp2.1 in WGpatients (59) . In support of a hypothetical stimulation of T cells by SAg, these authors also demonstrated polyclonality of the expanded T cell subsets (59, 60) . . Both studies showed that T cell expansions were present at a significantly higher rate in WGpatients than in healthy individuals, but were not associated with the presence of either S. aureus or SAg. Moreover, T cell expansions were generally of small extent, and did not simultaneously appear in both CD4and CD8subsets, suggesting that they had not been induced by SAg (manuscript in preparation).
Being the first dramatic manifestation of SAgstimulation,
T cell proliferation has received special attention as an in vivo reflection of SAgstimulation. Other effects of SAg on cellular immunity in vitro and in vivo certainly deserve further exploration in vasculitides. As previously mentioned, one of these effects consists in the induction of IL-10 mediated T cell anergy by chronic or repeated stimulation with the same SAg. Chronic exposure of T cells to SAg is possible in the case of chronic carriage of SAg-positive S. aureus strains. Since the upper airways are the major niche for S. aureus colonization in humans, it would be interesting to study the relationship between S. aureus carriage, SAg production and cytokine patterns in infiltrating T cells in these lesions. Moreover, it would be of interest to study whether resolution of active localized disease correlates with a switch to a Th2 cytokine production pattern, dominated by IL-10.
One of the unresolved puzzles of SAg-mediated T cell activation is the impact of the biphasic T cell response to SAg on the antigen-specific T cell response. A consequence of the initial SAg-induced T cell activation phase could be proliferation of autospecific T cells, expressing a SAg-responsive Vp chain. Evidently, this could result in disease exacerbation (61) . Studies in mousemodels of influenza virus infection showed that challenge of mice that had recovered from influenza virus infection, with SEBresulted in the generation of a strong cytotoxic response of influenza virus-specific CTLs (62, 63) . Moreover, infections with the influenza virus exacerbated subsequent T-cell responses to the SAg SEB (63 SpA, B cells from healthy individuals or patients with rheumatoid arthritis can produce VH3+rheumatoid factor (74, 75) . Interaction of SpA with soluble Ig can induce systemic complement activation (76) , with potentially detrimental consequences, considering that up to 50% of circulating Ig can be bound by SpA. In WG,the possible role of SpA can be conjectured from current information on the amino acid sequence of ANCA. Thus, the presence of ANCAwith a VH3-encoded heavy chain would indicate potential binding capacity of SpA. Sibilia et al found that three out of five IgM+, PR3-specific B cell lines obtained from a WGpatient expressed VH3-encoded ANCA.Two of these lines were clonally identical, suggesting that they had been derived from clonally expanded autospecific B cells (77) . These findings imply that, in the presence of SpA, PR3-specific B cells could be induced to proliferate, resulting in an amplification of the pool of autoantibodies. B cell activation and immunoglobulinproduction can also be mediated by classical staphylococcal T cell SAg. In vitro, high doses of SAg promote Ig production (78, 79) .
Importantly, T cell-dependent activation of B cells mediated by SAgcan bypass cognate interaction with a specific antigen, ensuring that production of Ig takes place even in the absence of the specific antigen (80 As another consequence of endothelial interaction with S. aureus, endothelial production of chemoattractants, such as MCP-1 and IL-8 (88-90) and pro-inflammatory cytokines, such as IL-6 and IL-ip (90) is upregulated. Recruitment of neutrophils and creation of an inflammatory milieu, have, in turn, consequences for endothelial integrity, since it has been postulated that in WG,vascular endothelial damage mayresult from the local production of proteolytic enzymes and reactive oxygen species by infiltrating neutrophils. However, endothelial damage may not only be mediated in the course of inflammation, but can be induced directly by internalization of S. aureus (91, 92). Endothelial apoptosis is dependent on the presence of the pore-forming staphylococcal cytolysin a-toxin (92, 93).
Our group has directed its attention towards a novel staphylococcal product, the cationic molecule staphylococcal acid phosphatase (94 
Outlook
Whenwe consider available and yet circumstantial data on the role of S. aureus in WG (Fig. 4) it becomes apparent that, despite the dramatic effects that this bacterium can have on an array of cell types of the host, these effects are not manifested in the patient. Most striking are our findings that carriage of staphylococcal strains that are positive for SAg genes by WGpatients is not associated with the expected expansion pattern of SAg-reactive T cells. Obviously, the study of the pathophysiologic significance of S. aureus in vivo is encumbered by various factors, among which treatment of the patient with either antibiotics or immunosuppressives is one of the more important ones. Moreover, one of the natural reactions of the immunesystem uponconfrontation with the microorganism is to mount a humoral immuneresponse, which contributes a part of the defense against the pathogen (101) (102) (103) . Frequently, these antibodies are directed against SAgand can inhibit the effect of these immunotoxins on T cells, as is seen in the case of preparations of pooled human
Ig for intravenous administration (103, 104) . Moreover, as mentioned above, study of S. aureus in vivo maybe encumbered by the fact that the microorganism is able to avoid detection by surviving inside an array of host cells.
Clearly, a delicate balance exists between the various components of the immunesystem and the microorganism, and it should be realized that interaction of S. aureus or its products with one cell type may have functional implications for other cell types, as well. At this point we speculate that, in the setting of WG,the two roles of S. aureus most worthwhile of investigation are its activating and lytic effect on endothelial cells and on phagocytic cells. Such studies would
give an insight into direct vascular damage by the bacterium Moreover, additional boosting of specific (auto)immunity maybe mediated by staphylococcal superantigens (right hand side of cartoon, rendered in colors). In this setting, staphylococcal B-and T-cell specific superantigens, such as SpA and enterotoxins, can potentially trigger autospecific B-and T-cells. Furthermore, activation of autoantigen aspecific T cells by superantigens could result in activation of autospecific B cells by cytokine production, as well. By virtue of these various mechanisms, it could be envisaged that ANCAmay be formed, eventually.
as well as indirect damage by release of proteolytic enzymes and reactive oxygen radicals from neutrophils. Moreover, it wouldallow us to estimate whetherS. aureus contributes to exposure of the autoantigen PR3 to the immunesystem (see section S. aureus and neutrophils). 
